These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8541229)

  • 41. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
    Hurd C; Dinda S; Khattree N; Moudgil VK
    Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.
    Jordan VC; Koch R
    Endocrinology; 1989 Apr; 124(4):1717-26. PubMed ID: 2924721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen.
    Howell A; Osborne CK; Morris C; Wakeling AE
    Cancer; 2000 Aug; 89(4):817-25. PubMed ID: 10951345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
    Leblanc K; Sexton E; Parent S; Bélanger G; Déry MC; Boucher V; Asselin E
    Int J Oncol; 2007 Feb; 30(2):477-87. PubMed ID: 17203231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
    Cao L; Gao H; Gui S; Bai G; Lu R; Wang F; Zhang Y
    J Neurooncol; 2014 Feb; 116(3):523-31. PubMed ID: 24407733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A potent specific pure antiestrogen with clinical potential.
    Wakeling AE; Dukes M; Bowler J
    Cancer Res; 1991 Aug; 51(15):3867-73. PubMed ID: 1855205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line.
    Dang VH; Nguyen TH; Choi KC; Jeung EB
    Toxicol Sci; 2007 Aug; 98(2):408-15. PubMed ID: 17504770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor-like macromolecule in MtTW15 rat pituitary tumors: effects of antiestrogens.
    Winneker RC; Welshons WV; Parsons JA
    Mol Cell Endocrinol; 1981 Sep; 23(3):333-44. PubMed ID: 7286385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GPR30 mediates estrone, estriol, and estradiol to suppress gonadotropin-releasing hormone-induced luteinizing hormone secretion in the anterior pituitary of heifers.
    Otsuka M; Kadokawa H
    J Reprod Dev; 2017 Oct; 63(5):519-525. PubMed ID: 28781349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
    Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ
    Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.
    Banerjee S; Saxena N; Sengupta K; Banerjee SK
    Biochem Biophys Res Commun; 2003 Jan; 300(1):209-15. PubMed ID: 12480545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The inhibition of prolactin synthesis in GH3 rat pituitary tumor cells by monohydroxytamoxifen is associated with changes in the properties of the estrogen receptor.
    Tate AC; Lieberman ME; Jordan VC
    J Steroid Biochem; 1984 Jan; 20(1):391-5. PubMed ID: 6708522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
    Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.